Pedro Huertas

Chief Development Officer, Ocata Therapeutics, Inc.

Companies

Inozyme Pharma, Inc.Officer Jul 23, 2020 to Jan 14, 2021¹
Eloxx Pharmaceuticals, Inc.Chief Medical Officer Dec 29, 2017 to May 18, 2018²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInozyme Pharma, Inc., Officer
2
SEC EDGAREloxx Pharmaceuticals, Inc., Chief Medical Officer